Consistent with the tumor growth inhibition data, bpAb-B/C and bpAb-B/D markedly decreased tumor cell proliferation (Ki-67 staining) compared with parental antibodies or IgG1 control (Figure 5, G and H). This evidence concerns the gene MKI67 and neoplasm.